Lei Lei, Zhou Yanrong, Wang Tiemao, Zheng Zhi, Chen Liang, Pan Youmin
Division of Cardiology, Department of Internal Medicine and Gene Therapy Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Department of Cardiothoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Int Immunopharmacol. 2022 Nov;112:109177. doi: 10.1016/j.intimp.2022.109177. Epub 2022 Aug 29.
Aortic dissection (AD) is a fatal vascular disease in absence of effective pharmaceutical therapy. Adenosine monophosphate-activated protein kinase α (AMPKα) plays a critical role in various cardiovascular diseases. Whether AMPKα is involved in the pathogenesis of aortic dissection remains unknown. We aimed to determine whether activation of AMPKα prevents the formation of AD.
Reduced expression of phosphorylated AMPKα (Thr172) and exacerbated phenotypic switching were observed in human aortic tissues from aortic dissection patients compared with those in tissues from controls. In vivo, the formation of aortic dissection in ApoE mice was successfully induced by continuous infusion of angiotensin II (AngII) for two weeks, characterized by the activation of vascular inflammation, infiltration of macrophages and phenotypic switching of vascular smooth muscle cells (VSMCs). rAAV2-mediated overexpression of constitutively active AMPKα (CA-AMPKα) enhanced the expression of phosphorylated AMPKα (Thr172) and attenuated AngII-induced occurrence of aortic dissection by suppressing the infiltration of macrophages, activation of vascular inflammation and phenotypic switching of VSMCs. The pathogenesis above was conversely exacerbated by rAAV2-mediated overexpression of dominant negative AMPKα2 (DN-AMPKα). In vitro, we demonstrated that the administration of an AMPK agonist (AICAR) or transfection of CA-AMPKα induced the activation of AMPKα and then ameliorated AngII-induced phenotypic switching in the VSMCs and inflammation in the bone marrow-derived macrophages (BMDMs). This could be reversed by the addition of AMPK inhibitor compound C or transfection of DN-AMPKα.
Impaired activation of AMPKα may increase the susceptibility to aortic dissection. Our findings verified the protective effects of AMPKα on the formation of aortic dissection and may provide evidence for clinical prevention or treatment.
在缺乏有效药物治疗的情况下,主动脉夹层(AD)是一种致命的血管疾病。单磷酸腺苷激活的蛋白激酶α(AMPKα)在各种心血管疾病中起关键作用。AMPKα是否参与主动脉夹层的发病机制尚不清楚。我们旨在确定激活AMPKα是否能预防主动脉夹层的形成。
与对照组组织相比,在主动脉夹层患者的人主动脉组织中观察到磷酸化AMPKα(Thr172)表达降低,且表型转换加剧。在体内,通过连续两周输注血管紧张素II(AngII)成功诱导ApoE小鼠形成主动脉夹层,其特征为血管炎症激活、巨噬细胞浸润以及血管平滑肌细胞(VSMC)表型转换。rAAV2介导的组成型活性AMPKα(CA-AMPKα)过表达增强了磷酸化AMPKα(Thr172)的表达,并通过抑制巨噬细胞浸润、血管炎症激活和VSMC表型转换减轻了AngII诱导的主动脉夹层的发生。相反,rAAV2介导的显性负性AMPKα2(DN-AMPKα)过表达加剧了上述发病机制。在体外,我们证明给予AMPK激动剂(AICAR)或转染CA-AMPKα可诱导AMPKα激活,进而改善AngII诱导的VSMC表型转换和骨髓来源巨噬细胞(BMDM)炎症。添加AMPK抑制剂化合物C或转染DN-AMPKα可逆转这种情况。
AMPKα激活受损可能增加主动脉夹层的易感性。我们的研究结果证实了AMPKα对主动脉夹层形成的保护作用,可能为临床预防或治疗提供依据。